Styrax Pharma Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 13.12 Cr
as on 07-12-2024
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 177.82 Cr
as on 07-12-2024
- Satisfied Charges ₹ 143.68 Cr
as on 07-12-2024
- Revenue -6.19%
(FY 2023)
- Profit 1.69%
(FY 2023)
- Ebitda -12.20%
(FY 2023)
- Net Worth 16.41%
(FY 2023)
- Total Assets -4.38%
(FY 2023)
About Styrax Pharma
The Corporate was formerly known as Vaya Jayanthi Drugs Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 13.12 Cr.
The company currently has active open charges totaling ₹177.82 Cr. The company has closed loans amounting to ₹143.68 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Styrax Pharma Private Limited India is Mohit Mittal as COMPANY SECRETARY. Suryadevara Rao, Lakshmi Suryadevara, and Sreenath Suryadevara serve as directors at the Company.
- CIN/LLPIN
U24230AP1995PTC098146
- Company No.
098146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Styrax Pharma Private Limited offer?
Styrax Pharma Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Safety Shoes, Fungicides, 4 Amino 1 2 4-Triazole, Organic Chemicals, Para Bromo Fluoro Benzene, API Intermediate.
Who are the key members and board of directors at Styrax Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suryadevara Rao  | Managing Director | 23-Jun-2014 | Current |
| Mohit Mittal | Company Secretary | 01-Mar-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lakshmi Suryadevara | Director | 18-Apr-2019 | Current |
| Sreenath Suryadevara | Director | 18-Apr-2019 | Current |
Financial Performance of Styrax Pharma.
Styrax Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.19% decrease. The company also saw a slight improvement in profitability, with a 1.69% increase in profit. The company's net worth Soared by an impressive increase of 16.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Styrax Pharma?
In 2023, Styrax Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Styrax Life Sciences Private LimitedActive 10 years 9 monthsSuryadevara Rao and Lakshmi Suryadevara are mutual person
- Styrax Laboratories Private LimitedActive 8 years 9 months
Suryadevara Rao, Lakshmi Suryadevara and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 04 Oct 2023 | ₹25.00 Cr | Open |
Others Creation Date: 17 Jul 2023 | ₹20.00 Cr | Open |
Yes Bank Limited Creation Date: 29 Mar 2023 | ₹1.50 Cr | Open |
How Many Employees Work at Styrax Pharma?
Styrax Pharma has a workforce of 260 employees as of Dec 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Styrax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Styrax Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
